Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
cancer
5
×
ipo
5
×
life sciences
5
×
national blog main
new york blog main
new york top stories
takeda pharmaceutical
5
×
boston top stories
boulder/denver blog main
boulder/denver top stories
deals
detroit blog main
detroit top stories
fda
indiana blog main
indiana top stories
national
national top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
startups
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
cancer immunotherapy
clinical trials
eli lilly
investing
novartis
sanofi
alexion pharmaceuticals
What
bio
roundup
pharmaceutical
drugs
ipo
medicines
typically
acquisitions
alzheimer’s
announced
appetite
bails
black
brand
bread
bridgebio
butter
buyout
cancer
capital
car
cash
ceo
collabs
companies
company’s
course
covid
daniel
deal
develop
development
diabetes
diamond’s
different
discover
drug
eli
emerges
experimental
Language
unset
Current search:
ipo
×
cancer
×
" life sciences "
×
" takeda pharmaceutical "
×
@xconomy.com
4 years ago
Bio Roundup: Gilead’s $4.9B Deal, COVID-19 Collabs, IPO Plans & More
@xconomy.com
4 years ago
Schrödinger Sets Course for IPO to Support Growing Internal Pipeline
@xconomy.com
4 years ago
Bio Roundup: Ichnos Emerges, Beyond CAR-T, BridgeBio Bails & More
@xconomy.com
5 years ago
Bio Roundup: Alzheimer’s Fail, Drug Price Plan, Gene Therapies & More
@xconomy.com
5 years ago
Bio Roundup: #JPM19 Notes, Loxo Buyout, Black Diamond’s Cash & More